Univariate survival analysis revealed that OS in AD patients was not associated with TZAP expression (2595.66 ± 336.70 vs. 2679.27 ± 332.14 days, p = 0.131; Figure 2A); however, a shorter DFS was found in AD patients with lower TZAP expression (2422.98 ± 490.78 vs. 2833.90 ± 372.97 days, p = 0.047; Figure 2B). This evidence concerns the gene ZBTB48 and Alzheimer disease.